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GTP Cyclohydrolase Feedback Regulatory Protein
Controls Cofactor 6-Tetrahydrobiopterin Synthesis
in the Cytosol and in the Nucleus of Epidermal
Keratinocytes and Melanocytes
Bhaven Chavan1, Johanna M. Gillbro1, Hartmut Rokos1,2 and Karin U. Schallreuter1,2
(6R)-L-Erythro 5,6,7,8 tetrahydrobiopterin (6BH4) is crucial in the hydroxylation of L-phenylalanine-, L-tyrosine-,
and L-tryptophan-regulating catecholamine and serotonin synthesis as well as tyrosinase in melanogenesis. The
rate-limiting step of 6BH4 de novo synthesis is controlled by guanosine triphosphate (GTP) cyclohydrolase I
(GTPCHI) and its feedback regulatory protein (GFRP), where binding of L-phenylalanine to GFRP increases
enzyme activities, while 6BH4 exerts the opposite effect. Earlier it was demonstrated that the human epidermis
holds the full capacity for autocrine 6BH4 de novo synthesis and recycling. However, besides the expression of
epidermal mRNA for GFRP, the presence of a functioning GFRP feedback has never been shown. Therefore, it
was tempting to investigate whether this important mechanism is present in epidermal cells. Our results
identified indeed a functioning GFRP/GTPCHI axis in epidermal keratinocytes and melanocytes in the cytosol,
adding the missing link for 6BH4 de novo synthesis which in turn controls cofactor supply for catecholamine
and serotonin biosynthesis as well as melanogenesis in the human epidermis. Moreover, GFRP expression and
GTPCHI activities have been found in the nucleus of both cell types. The significance of this result warrants
further investigation.
Journal of Investigative Dermatology (2006) 126, 2481–2489. doi:10.1038/sj.jid.5700425; published online 15 June 2006
INTRODUCTION
Both epidermal melanocytes and keratinocytes have the full
capacity to synthesize and recycle (6R)-L-erythro 5,6,7,8,
tetrahydrobiopterin (6BH4) (Schallreuter et al., 1994). 6BH4 is
a crucial cofactor for the three aromatic hydroxylases
including phenylalanine hydroxylase (EC 1.14.16.1), tyrosine
hydroxylase (EC 1.14.16.2), and tryptophan hydroxylase (EC
1.14.16.4). It also regulates the nitric oxide synthases (EC
1.14.13.39) as well as glyceryl ether monooxygenase
(EC 1.14.16.5). In addition, this cofactor plays a major role
in skin pigmentation since the redox balance of 6BH4 directly
influences tyrosinase (EC 1.14.18.1) activities (Wood et al.,
1995). 6BH4 is synthesized de novo in a three-step reaction
via guanosine triphosphate (GTP) cyclohydrolase I (EC
3.5.4.16, GTPCHI), followed by 6-pyruvoyl-tetrahydropterin
synthase (EC 4.6.1.10) and finally sepiapterin reductase
(EC1.1.1.153). After 6BH4 has been utilized as a cofactor, it
produces pterin 4a-carbinolamine due to the molecular
transfer of oxygen. This metabolite is then fully recycled in
a two step enzymatic reaction via pterin 4a-carbinolamine
dehydratase (EC 4.2.1.96), and dihydropteridine reductase
(EC 1.6.99.7).
GTPCHI is the rate-limiting enzyme in the de novo
synthesis of 6BH4 catalyzing the conversion of GTP to 7,8
dihydroneopterin triphosphate in a series of complex reac-
tions, beginning with the opening of the imidazole ring of
GTP and the removal of the purine carbon atom 8 of GTP
giving rise to formate release and finally yielding 7,8
dihydroneopterin triphosphate (Nar et al., 1995; Tho¨ny
et al., 2000; Rebelo et al., 2003).
The de novo synthesis of 6BH4 is tightly controlled by
GTPCHI feedback regulatory protein (GFRP). Already in 1984
it had been recognized that GTPCHI was under feedback
inhibition by 6BH4, although the underlying mechanism and
control was at first not fully understood (Bellahsene et al.,
1984). Later it was shown that the presence of high 6BH4
levels downregulates GTPCHI activity via GFRP, while
L-phenylalanine upregulates this enzyme (Harada et al.,
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1993). Hence, GFRP controls an elegant feedback mechan-
ism in the de novo synthesis of 6BH4.
The presence of GFRP has been detected in many tissues
including the liver and the brain (Harada et al., 1993;
Milstien et al., 1996; Kapatos et al., 1999; Park et al., 2002).
Although the presence and function of 6BH4 de novo
synthesis/recycling was demonstrated in the human epider-
mis already in 1994, translation and function of GFRP in
epidermal cells has never been shown (Schallreuter et al.,
1994, 1998). Therefore, we asked the question whether a
functioning GFRP/GTPCHI axis is also present in the human
epidermis in control of 6BH4 de novo synthesis. Our results
demonstrate for the first time that this feedback regulatory
protein is indeed expressed and functioning primarily in
basal/undifferentiated keratinocytes as well as in melanocytes
while this mechanism is downregulated upon differentiation.
These results are in agreement with the earlier observation
that 6BH4 de novo synthesis/recycling is much more
predominant in the basal layer compared to suprabasal layers
(Schallreuter et al., 1994). In addition, we detected GFRP
together with GTPCHI in the nucleus of both cell types and
we were able to show GTPCHI activity in this organelle.
The nature of this observation is still not fully understood at
this time point. Clearly this observation warrants further
investigation.
RESULTS
GFRP protein is expressed in situ
Protein expression of GFRP in the human epidermis has never
been reported. Using 3 mm punch biopsies from healthy
controls with skin phototype III (Fitzpatrick classification), we
here demonstrate the presence of this regulatory protein
within the epidermal compartment utilizing immunofluores-
cence labelling with a specific GFRP antibody (Kalivendi
et al., 2005). The protein is present throughout the human
epidermis but it is more predominant in the basal layer
(Figure 1a). Image analysis of the fluorescence yields a 3-fold
increase in intensity in this layer compared to suprabasal
layers (Figure 2a). In order to test whether this protein is also
present within melanocytes, we used the melanosomal gp100
protein (NKI/beteb) (Figure 1b) and followed the overlay of
both GFRP and NKI/beteb. The result demonstrates the
presence of GFRP in some but not all melanocytes,
suggesting subpopulations within this cell type under in situ
conditions (Figure 1c).
GFRP is expressed in human epidermal melanocytes and
keratinocytes in the cytosol as well as in the nucleus
Melanocytes express GFRP under in vitro conditions in the
dendrites and in the nucleus (Figure 3a). Electron microscopy
coupled with immuno-gold labelling further demonstrated
the presence of GFRP in the nucleus with multiple gold
particles bound in this organelle and also on the nuclear
membrane (Figure 3e). Moreover, a positive granular co-
localization with gp100 (NKI/beteb) suggests the presence of
this regulatory protein within the melanosomes (Figure 3b
and c).
Keratinocytes express GFRP under in vitro conditions in
the cytosol and in the nucleus in a diffuse and in a granular
pattern. The expression is stronger in undifferentiated
keratinocytes compared to differentiated cells (Figure 4a
and d). This result is in agreement with the in situ observation
(Figure 1a).
GFRP colocalizes with GTPCHI in situ and in vitro
Since it has already been demonstrated earlier that GTPCHI is
transcribed and translated into a functioning protein in the
human epidermis (Schallreuter et al., 1994), we wanted to
know whether the enzyme colocalizes with GFRP expres-
sion. Therefore, we utilized a specific GTPCHI antibody
(Hesslinger et al., 1998) in addition to GFRP labelling. The
result shows expression of GTPCHI as expected throughout
the human epidermis with a more pronounced expression in
the basal layer (Figure 2b). This finding is in agreement with
highest GTPCHI enzyme activities in undifferentiated kerati-
nocytes as previously reported (Schallreuter et al., 1994).
Even more exciting was the overlay of both immuno-
reactivities which shows strong GTPCHI colocalization with
its regulatory protein GFRP in the basal layer which is much
weaker in suprabasal layers (Figure 2c). Moreover, both
proteins colocalize in epidermal keratinocytes and melano-
cytes under in vitro conditions supporting the presence of
GFRP feedback regulation for 6BH4 de novo synthesis in the
epidermal compartment (Figures 4 and 5).
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Figure 1. GFRP protein is expressed in situ. (a) GFRP (FITC labelling) is
predominantly expressed in the basal layer of the epidermis with much
weaker expression in the suprabasal layers, (b) NKI/beteb (TRITC labelling)
shows melanocytes, and (c) overlay of (a/b) identifies colocalization (yellow)
in some melanocytes ( ) suggesting the presence of a melanocyte
subpopulation (original magnification  400).
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Western blot analysis supports GFRP protein expression within
the cytosol and the nucleus of epidermal melanocytes and
keratinocytes
In order to substantiate the presence of GFRP in epidermal
cells, Western blot analysis was employed. The protein was
detected in cytosolic cell extracts as well as in nuclear
extracts from melanocytes and keratinocytes. The bands at
the 10 kDa molecular weight marker corresponded to the
monomer of GFRP of 9.5 kDa (Figure 6) (Milstien et al., 1996;
Yoneyama et al., 1997). This result was in agreement with the
band found in human liver lysate (Abcam Ltd, Cambridge,
UK) which was used as positive control (Figure 6 inset).
Unfortunately, we could not further substantiate this result by
specific blocking because no blocking peptide is currently
available.
Epidermal GTPCHI enzyme activity is coupled to GFRP in
human epidermal melanocytes and keratinocytes
In order to prove the functionality of the GFRP protein in
melanocytes and keratinocytes, we followed neopterin
formation by adding rhGTPCHI (Ichinose et al., 1995) in
the presence and absence of 6BH4 and L-phenylalanine. The
rationale for this approach was that this co-factor is a negative
regulator of GTPCHI, whereas L-phenylalanine is a positive
upregulator (Harada et al., 1993). The first step was to ensure
that the cell extracts of both epidermal cells had indeed
active GTPCHI activity. For this purpose we followed
neopterin formation as outlined in the method section
(Schallreuter et al., 1994; Werner et al., 1997). Both cell
types showed GTPCHI activity (data not shown). Based on
this result we then determined neopterin formation in the
presence and absence of 6BH4 and L-phenylalanine by
adding rhGTPCHI to test GFRP/GTPCHI coupling. The result
showed indeed a significant decrease in neopterin formation
with 6BH4 (Figure 7). Moreover, a significant increase was
observed in the presence of L-phenylalanine in a concentra-
tion-dependent manner (Figure 7). Both effects were absent
when 6BH4 and L-phenylalanine were not added (Figure 7).
Based on these result we can conclude that epidermal
keratinocytes and melanocytes have the capacity to control
GTPCHI via GFRP which in turn regulates 6BH4 de novo
synthesis and consequently catecholamine and serotonin
synthesis as well as nitric oxide synthesis in these cells (Klatt
et al., 1992; Schallreuter et al., 1992; Shimizu et al., 1998;
Slominski et al., 2002, 2003; Gillbro et al., 2004).
Nuclear extracts of epidermal melanocytes and keratinocytes
have GTPCHI activity
After demonstration of GFRP and GTPCHI immuno-reactivity
in the nucleus of epidermal keratinocytes and melanocytes
by labelling and Western blot, it was tempting to test possible
GTPCHI activity in this organelle. For this purpose, we
followed again neopterin formation in nuclear extracts in the
presence and absence of GTP, the natural substrate for
GTPCHI. HPLC analysis showed a significant increase of the
neopterin peak in the presence of GTP confirming GTPCHI
activity in the nucleus of these cells (Figure 8). The
significance of nuclear GTPCHI activities is currently not
fully understood. Whether GFRP is indeed coupled to
GTPCHI in this organelle is currently under further investi-
gation.
DISCUSSION
Both epidermal melanocytes and keratinocytes hold the full
capacity to synthesize and recycle 6BH4 (Schallreuter et al.,
1994). GTPCHI is the rate-limiting enzyme in the de novo
synthesis of this cofactor catalyzing the conversion of GTP to
7,8 dihydroneopterin triphosphate. This enzyme is regulated
at the transcriptional, translational, and also at the level of
enzyme activity via GFRP (Ziegler et al., 1990, 1993; Werner
et al., 1991; Togari et al., 1992; Harada et al., 1993; Gu¨tlich
et al., 1994; Tho¨ny et al., 2000; Hwu et al., 2003).
Depending on the balance of L-phenylalanine and 6BH4,
this protein can either up- or downregulate GTPCHI activity
(Harada et al., 1993; Yoneyama et al., 1997; Yoneyama and
Hatakeyama, 2001; Maita et al., 2002, 2004). Hence, this
mechanism leads to an intricate regulation of 6BH4 de novo
synthesis.
The presence of a functioning GFRP feedback regulation
has been documented in various cell types including liver
and neuronal cells (Milstien et al., 1996; Kapatos et al., 1999;
Park et al., 2002), but except mRNA expression in epidermal
melanocytes and keratinocytes (Schallreuter et al., 1998) a
functioning GFRP/GTPCHI axis has not been shown in these
cells. From the data presented herein, we now show the
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Figure 2. Epidermal GFRP and GTPCHI are co-expressed in situ. (a) GFRP
(FITC labelling) expression with corresponding image analysis of the in situ
immuno-reactivity, (b) GTPCHI (TRITC labelling) expression with corre-
sponding image analysis of the in situ immuno-reactivity, and (c) overlay of
(a/b) shows strongest colocalization of both proteins in the basal layer and in
the stratum corneum. There is no colocalization in the suprabasal layers
(original magnification  400). (Units are expressed as arbitary units.)
www.jidonline.org 2483
B Chavan et al.
Regulation of 6-Tetrahydrobiopterin Synthesis by GFRP/GTPCHI
50 m 50 m 50 m
0.2 m0.5 m
a b c
d e
Figure 3. In vitro expression of GFRP in human epidermal melanocytes. (a) GFRP (FITC labelling) is expressed in a granular pattern throughout the entire
cell including the nucleus, (b) NKI/beteb (TRITC labelling) identifies melanocytes, (c) overlay of (a/b) shows colocalization with NKI/beteb (yellow)
suggesting the presence of GFRP in melanosomes (original magnification  400), (d) electron microscopy showing the nucleus of an epidermal
melanocyte (bar¼ 0.5mm), and (e) further magnification of nuclear region illustrating the binding of multiple gold particles within this region indicating
GFRP presence within this organelle (bar¼ 0.2 mm).
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Figure 4. GFRP and GTPCHI expression in undifferentiated and differentiated keratinocytes. Undifferentiated keratinocytes (a) GFRP (FITC labelling),
(b) GTPCHI (TRITC labelling), and (c) overlay of (a/b). The high expression of GFRP and GTPCHI in undifferentiated cells is in agreement with high GTPCHI
activities as shown earlier (Schallreuter et al., 1994). Differentiated keratinocytes (d) GFRP (FITC labelling), the expression is reduced upon differentiation in the
cytosol as well as in the nucleus (e) GTPCHI (TRITC labelling), the expression does not differ in the cytosol and in the nucleus. (f) Overlay of (d/e).
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expression of this protein throughout the human epidermis
with stronger localization of GFRP in the basal layer
compared to suprabasal layers (Figures 1a and 2a). This
result is in agreement with GTPCHI activities and with 6BH4
levels in the human epidermal compartment as reported
previously (Schallreuter et al., 1994). GFRP expression under
in vitro conditions showed a very granular staining pattern in
the cytosol as well as in the nucleus of both cell types. This
result suggests that GFRP may be localized within vesicles
(Figures 3a, 4a, and d). Colocalization with gp100 (NKI/
beteb) indicated the presence of GFRP in melanosomes
(Figure 3c). This result was supported by immuno-gold
electron microscopy where gold particles were indeed found
in these organelles (data not shown). However, the presence
of GFRP in melanosomes needs further investigation.
In our attempt to test whether the immuno-reactive GFRP
protein was actually coupled to GTPCHI enzyme activity, we
used both regulators of this protein, that is 6BH4 (negative
feedback) and L-phenylalanine (positive feedback) in cell
extracts of keratinocytes and melanocytes. Our results proved
indeed a significant reduction in the presence of 6BH4 while
L-phenylalanine upregulated neopterin formation in a con-
centration-dependent manner (Figure 7). Therefore, we can
conclude that GFRP/GTPCHI-positive feedback regulation is
taking place in these cells (Figure 7). Clearly the expression of
GFRP follows GTPCHI activities with higher enzyme
activities in undifferentiated keratinocytes and in melano-
cytes underlining once more the importance of 6BH4 for the
turnover of the essential amino acid L-phenylalanine to
L-tyrosine for catecholamine and serotonin synthesis in cell
proliferation and pigmentation (Schallreuter et al., 1992,
1995; Slominski et al., 2002, 2003; Gillbro et al., 2004).
The presence of GFRP expression in the nucleus as shown
by immuno-reactivity, electron microscopy, and Western blot
is novel, but the function needs to be shown. In this context it
is noteworthy that the presence of all enzymes for 6BH4
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Figure 5. Co-expression of GFRP and GTPCHI in human epidermal
melanocytes. (a) GFRP (FITC labelling), (b) GTPCHI (TRITC labelling), both
proteins are expressed in a granular pattern in the cytosol and in the nucleus.
(c) Overlay of (a/b) shows the strongest colocalization (yellow) in the nucleus
indicating the presence of both proteins in this organelle.
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Figure 6. Western blot analysis confirms the presence of GFRP in the cytosol
and in the nucleus of melanocytes and keratinocytes. (a) Analysis of cytosolic
extracts. Lane 1¼ ladder, lane 2¼ undifferentiated keratinocytes, lane
3¼ differentiated keratinocytes, and lane 4¼melanocytes. The inset shows
the presence of GFRP in human liver lysate as a positive control. Lane
1¼ ladder, lane 2¼ positive control, and lane 3¼negative control.
(b) Analysis of nuclear extracts. Lane 1¼ ladder, lane 2¼ negative control,
lane 3¼ undifferentiated keratinocytes, lane 4¼differentiated
keratinocytes, and lane 5¼melanocytes. These results confirm the presence
of GFRP in the cytosol and in the nuclei of epidermal cells. NB: Blocking
peptides for GFRP are not available at this time.
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Figure 7. GFRP activity is present in human epidermal melanocytes. In the
absence of GTP neopterin is not detected using HPLC analysis as outlined in
methods. The addition of GTP leads to a significant increase in neopterin
formation compared to the control which in turn mirrors GTPCHI activity
(**Po0.01). Addition of 6BH4 the negative regulator of GTPCHI activity via
GFRP results in a decrease in enzyme activity. GTPCHI is significantly
upregulated in a concentration-dependent manner in the presence of
L-phenylalanine (*Po0.05). This result proves positive GFRP feedback
regulation on GTPCHI activity in melanocytes.
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de novo synthesis was demonstrated in the nucleus of
transfected COS-1 cells while only GTPCHI and 6-pyru-
voyl-tetrahydropterin synthase were found in rat brain
nucleus (Elzaouk et al., 2004). These authors did not show
GFRP in the nucleus. Owing to low amounts of nuclear
extracts at this point, we were not able to test yet the coupling
of GFRP/GTPCHI as shown in the cytosol. Further research is
on the way in our laboratory to get a more detailed
understanding for the presence of 6BH4 de novo synthesis
and its role in this organelle.
In summary, human epidermal melanocytes and keratino-
cytes have the capacity to regulate 6BH4 de novo synthesis
via the GFRP/GTPCHI axis. The expression of GFRP follows
GTPCHI. This result also underlines the importance of
intracellular L-phenylalanine uptake and turnover in these
cells in order to provide sufficient L-tyrosine for both
catecholamine synthesis and melanogenesis (Schallreuter
and Wood, 1999; Marles et al., 2003; Gillbro et al., 2004).
The importance of the GFRP/GTPCHI axis for 6BH4 de novo
synthesis is summarized in Figure 9.
MATERIALS AND METHODS
Cell cultures
Primary cell cultures of human epidermal melanocytes and
keratinocytes were established from full thickness skin received as
surgical waste from routine cosmetic enhancements such as face-lifts
and breast reduction tissue. Briefly, after removal of fat, the skin was
washed in a solution containing 5% penicillin/streptomycin and 5%
fungisone followed by dispase treatment (Roche Applied Science,
Roche Diagnostics Corporation, Indianapolis, IN), for 12 hours at
41C. The epidermis was peeled off and placed into sterile phosphate-
buffered saline (PBS) and then transferred for trypsinization (1
trypsin/EDTA, Sigma, Dorset, UK) for 10 minutes at 371C. The cell
suspension was centrifuged at 1,000 g and re-suspended in
MCDB154 medium (Cascade Biologics, Mansfield, Nottingham-
shire, UK) containing 1% penicillin/streptomycin and 0.1 mM
calcium and finally seeded into T75 flasks (Scientific Laboratory
Supplies, Nottingham, UK).
In order to establish pure keratinocyte or melanocyte cultures,
cells were grown to 70–80% confluence, followed by sequential
trypsination in MCBD154 medium containing either melanocyte or
keratinocyte supplements (Cascade Biolobics, Mansfield, Notting-
hamshire, UK). To promote differentiation of keratinocytes, the
calcium concentration was increased to 2.5 mM and growth factors
were removed (Pittelkow and Shipley, 1989). Differentiation was
confirmed by the expression of the corresponding cytokeratins
(Abcam, Cambridge, UK) (data not shown). For immuno-reactivity
studies, keratinocytes or melanocytes were seeded into chamber
slides (Nalge Nunc International, Naperville, IL) and cultured for
48 hours, followed by removal of the medium and a 3 wash in
sterile PBS, pH 7.4. Cells were fixed in ice-cold methanol for
5 minutes prior to the staining procedure.
Human skin biopsies
After signed consent, full thickness skin 3 mm punch biopsies were
taken under local anesthesia from sun-unexposed skin of the inner
proximal arm from healthy human volunteers (n¼ 3; skin phototype
III, Fitzpatrick classification) and embedded in optimal cutting
temperature compound (Sakura, RA Lamb, Eastbourne, UK). The
tissue was cut in 4–5 mm sections using a Leica CM3050 S cryostat.
Sections were placed onto poly-L-lysine-coated slides and stored at
801C until further use.
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Figure 8. GTPCHI is active in the nucleus of human epidermal melanocytes.
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absent in the control extract (**Po0.01). Comparison of enzyme activities
from nuclear and cytosolic extracts shows an 11-fold higher activity in the
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Figure 9. The importance of the GFRP/GTPCHI axis for catecholamine/
serotonin synthesis and melanogenesis in human epidermal keratinocytes
and melanocytes. L-phenylalanine enters the cell via the large neutral amino
acid transporter (LNAT). Binding of L-phenylalanine to GFRP regulates 6BH4
de novo synthesis by increasing GTPCHI activity, whereas 6BH4 binding
exhibits the opposite effect (Harada et al., 1993; Yoneyama and Hatakeyama,
1998, 2001; Maita et al., 2002, 2004). The cofactor is required for
L-phenylalanine turnover to L-tyrosine via phenylalanine hydroxylase
and for tyrosine hydroxylase isoform I to initiate catecholamine synthesis
in keratinocytes and melanocytes as well as melanogenesis in
melanocytes (Schallreuter and Wood, 1999; Marles et al., 2003; Gillbro
et al., 2004). Moreover, 6BH4 is needed for the turnover of L-tryptophan
to 5-OH-tryptophan finally yielding serotonin and melanotonin (Slominski
et al., 2002, 2003).
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This study was approved by the local Ethics Committees and was
in agreement with the Declaration of Helsinki Principles.
In situ double immunofluorescence studies
Frozen slides were air dried for 60 minutes at room temperature (RT),
fixed prior to staining in ice-cold methanol and blocked in 10%
normal donkey serum (NDS, Jackson Immuno Research Labora-
tories, Cambridgeshire, UK) for 90 minutes at RT followed by a
5 minutes wash in PBS. To demonstrate the presence of GFRP in situ,
we used a well-characterized primary rabbit anti-human antibody (a
kind gift from K. Hatakeyama, Japan) diluted 1:1,000 in 1% normal
donkey serum and incubated for 90 minutes at RT. For GTPCHI in
situ detection, we utilized a mAb rat anti-mouse antibody (a kind gift
from C. Hesslinger, Germany) diluted 1:20 and incubated for 5 hours
at RT. The slides were washed in PBS twice for 5 minutes followed
by a wash in Tween 20 (Bio-Rad Laboratories, Life Science Group,
CA) for 5 minutes with a final wash in PBS. Sections were air dried
followed by incubation at RT for 1 hour with a fluorescent secondary
antibody (Jackson Immuno Research Laboratories, Cambridgeshire,
UK) in a dilution of 1:100 FITC-conjugated donkey anti-rabbit for
GFRP or tetramethyl rhodamine isothiocyanate-conjugated donkey
anti-rat (TRITC) for GTPCHI, followed by 3 washing in PBS. In
addition, we used for the detection of melanocytes the melanocyte-
specific gp100 protein (NKI beteb, Monosan Antibodies, Buckin-
ghamshire, UK) in a dilution 1:20 overnight at 41C. Finally, the
slides were dried and mounted in Vectashield Mounting Medium
with 4,6-diamino-2-phenylindole (Vector Laboratories, CA) and
viewed under a Leica DMIRB/E fluorescence microscope (Wetzlar,
Germany). Images were captured using a color video camera
coupled to a computer using Image Grabber PCI graphics program
(Optivision, Osset, West Yorkshire, UK). In addition, some pictures
were captured using a Nikon Eclipse 80i microscope with a
DS-U101 Nikon camera coupled to a Nikon ACT-2U capture
program (Nikon, Europe).
Paint Shop ProTM 7 was utilized to merge the two different
fluorochromes in order to follow possible colocalization.
In vitro immunofluorescence labelling of keratinocytes and
melanocytes
For immuno-labelling of cultured cells the same procedure was used
as described above. Keratinocytes were incubated for 2.5 hours at RT
with anti-GFRP antibody at the dilution 1:5,000. Melanocytes were
incubated overnight at 41C with a dilution 1:500.
GTPCHI was used in the dilution 1:10 and both keratinocytes and
melanocytes were incubated overnight at 41C. In order to follow
possible expression in melanosomes, melanocytes were incubated
overnight at 41C with the melanocyte-specific gp100 protein (NKI
beteb) in the dilution 1:20.
Quantification of fluorescence intensity
For quantification of fluorescence intensity, we utilized IPLab
v3.6.5a (Nikon, Europe) software following the manufacturer’s
protocol. The fluorescence was expressed in arbitary units.
Electron microscopy of GFRP utilizing immuno-gold labelling
Epidermal melanocyte cultures (passages 3–5) (n¼ 2) were harvested
via trypsinization, followed by gentle centrifugation at 1,000 r.p.m.
at 41C. The pelleted cells were subsequently fixed for 1 hour at RT in
a solution of 0.5% glutaraldehyde (Agar Scientific, Stanstead, UK)
and 2% paraformaldehyde (Sigma, Dorset, UK) in 0.1 M sodium
cacodylate buffer (Sigma, Dorset, UK), containing 0.027 mM CaCl2
(Sigma, Dorset, UK), buffered to pH 7.4.
After fixation, cells were washed in PBS over 25 minutes, and
rinsed in 0.1 M glycine (Sigma, Dorset, UK) in PBS, for 5 minutes,
before being pelleted through 1% low melting point agarose (Bio-
Rad Laboratories, CA) in PBS. The cell/agar blocks were dehydrated
in graded series of ethanol and infiltrated with hydrophilic Unicryl
resin (British BioCell International, Cardiff, Wales, UK), followed by
polymerization using UV light (360 nm) of 2 8 W for 3 days at 41C.
Ultrathin sections (90 nm) were cut using a Reichert-Jung
ultramicrotome (Vienna, Austria) and mounted on 200 mesh nickel
grids coated with a carbon film (Agar Scientific).
Sections processed as above were blocked in 10% normal goat
serum and 2% BSA in PBS (pH 8.2) for 1 hour (1% normal goat
serum in the same blocking buffer, was used to dilute the primary
and secondary antibodies). The sections were washed twice in PBS
containing 2% BSA (pH 8.2) and incubated with the GFRP primary
antibody at 1:200 for 18 hours at 41C. Following incubation, the
sections were washed in 2% BSA in PBS, and incubated in a 1:60
dilution of the secondary goat anti-rabbit antibody conjugated to
10 nm gold particles (British BioCell International, Cardiff, Wales,
UK) for 1 hour at RT. Following a final wash in distilled water, the
sections were lightly counterstained with 2% uranyl acetate and
Reynold’s lead citrate solution and examined and photographed
using a JEM-1200 EX transmission electron microscope (Jeol Tokyo,
Japan).
Whole cell and nuclear extract preparation from melanocyte
and keratinocyte cell cultures
Medium was aspirated from the flask and washed with ice-cold PBS
containing phosphatase inhibitors. Cells were gently detached and
centrifuged at 1,000 g for 10 minutes. The pellet was resuspended
in reaction buffer (50 mM Tris-HCl pH 7.8, 300 mM KCl, 2.5 mM
EDTA, and 10% glycerol) and homogenized on ice. The homogenate
was then centrifuged for 1 hour at 76,000 g and the supernatant
obtained was used as the whole-cell extract which was aliquoted
and stored at 801C until further use.
Nuclear extracts from undifferentiated keratinocytes and mela-
nocytes were prepared using a nuclear extraction kit (Active Motif,
Rixensart, Belgium) following the manufacturer’s instructions. The
cell pellet was obtained as described above and was resuspended in
hypotonic buffer (Active Motif, Rixensart, Belgium) and incubated
for 15 minutes on ice, followed by thorough mixing and finally
centrifuged at 22,000 g for 30 seconds. The pellet was resus-
pended in complete lysis buffer for 30 minutes on ice and then
vortexed and centrifuged at 13,000 g for 10 minutes. The super-
natant collected was used as the nuclear extract. In order to test the
purity of the extract, the lactic dehydrogenase assay was utilized
(Howell et al., 1979). This enzyme is only active in the cytosol and
therefore a good marker for detection of cytosolic contamination.
The protein content was determined at the optical density 280 nm
using the method of Kalb and Bernlohr (1977).
Western blotting
Cytosolic and nuclear extracts from keratinocytes and melanocytes
were separated in 10% SDS-PAGE and proteins transferred
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to a polyvinylidene difluoride membrane (ImmobilonTM-P Millipore,
Bedford, UK). The membrane was blocked with 0.5% gelatine
in Tris-buffered saline containing 0.1% (v/v) Tween-20 buffer
(150 mM NaCl, 20 mM Tris, 0.047% Tween, pH 7.4) and incubated
overnight with rabbit anti-human GFRP antibody (dilution 1:20,000).
The blot was washed and incubated for 1 hour at RT with an
anti-rabbit IgG peroxidase-conjugated antibody (Fc specific,
dilution 1:5,000, Cell Signalling Technology Inc., Beverley, MA).
Visualization of GFRP bands was performed using modified
enhanced chemiluminescence fixed on a film sheet (X-OMATTM
Kodak, USA).
Neopterin analysis in whole cell extract from keratinocytes and
melanocytes to follow coupling of GFRP/GTPCHI
The method used was adapted from Werner et al. (1997) and
slightly modified. For this assay cell extract from melanocytes
and keratinocytes was utilized. The reaction contained 110ml
of cell extract, 1ml recombinant human GTPCHI (a generous gift
from Dr Ichinose, Japan) (Suzuki et al., 1999), 300 mM GTP (Sigma,
Aldrich, UK) in a total volume of 120ml. In addition, differing
concentrations of 6BH4 (3 and 0.5 mM final concentration) and
L-phenylalanine (10, 0.5, and 0.1 mM final concentration) were
added to see negative and positive regulation via GFRP. The reaction
was incubated for 2.5 at 371C in the dark. The pH was adjusted to
3 with 1 N phosphoric acid followed by oxidation with 1% iodine
and 2% potassium iodide at RT in the dark. The oxidation
was stopped with 3% ascorbic acid and the sample was depho-
sphorylated using alkaline phosphatase (Roche Diagnostics
GmbH, Penzberg, Germany). Prior to HPLC analysis the samples
were de-proteinized and finally analyzed using a Dynamax HPLC
system and fluorescence detector (Hitachi RF-535, Shimadzu, Milton
Klynes, Bucks, UK) along with sphereclone columns (Phenomenex,
Macclesfield, Cheshire UK). The mobile phase contained 3%
methanol, 0.1% phosphoric acid (1 M) in HPLC grade water and
the organic solvent was HPLC grade methanol (Fisher Scientific,
Loughborough, UK). The detector was set at an lex345 and lex450 .
Determination of enzyme activity was based on two independent
assays.
GTPCHI activity in nuclear extracts from keratinocytes and
melanocytes utilizing HPLC
The method used was as described above, however no rhGTPCHI
was added and GTP was added in excess (2 mM final concentration).
Neopterin detection was carried out under the same HPLC
conditions as described above.
Statistical analysis
Data from multiple experiments are expressed as means7SE
Statistical significance was determined with paired and unpaired
Student’s t-test.
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